Michelle Childs
Michelle Childs is the director of the Drugs for Neglected Diseases Initiative (DNDi), an organization focused on developing and delivering new treatments for neglected diseases. She has been a prominent advocate for equitable access to medicines and health technologies, emphasizing the importance of addressing healthcare disparities, particularly in resource-limited settings. Recently, she highlighted the significance of ongoing negotiations at the WHO for a groundbreaking pandemic treaty aimed at improving global preparedness and response to future pandemics.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Spain | 1 | 8.00 | 0.07% | +0% | 46,754,778 | 32,334 | $1,400,000 | 968$ |
| Egypt | 1 | 8.00 | 0.07% | +0% | 102,334,404 | 70,236 | $303,000 | 208$ |
| Totals | 2 | 149,089,182 | 102,570 | $1,703,000 | 1,176$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Egypt:
Michelle Childs described the treaty as containing critical provisions that could transform the global pandemic response.
8
Spain:
Michelle Childs, director of Political Advocacy for DNDi, emphasized the importance of ensuring equitable access to treatments developed with public funds.
8
Spain:
Michelle Childs emphasized the importance of the pandemic agreement as a crucial reference point.
7
Colombia:
Michelle Childs commented on the pandemic agreement, highlighting its imperfections but noting it creates a new foundation for saving lives during future health emergencies.
7
Slovakia:
Michelle Childs, the director of the Drugs for Neglected Diseases Initiative (DNDi), noted that if the text is adopted, it will be the first of its kind in the history of international agreements.
9